Cambridge Investment Research Advisors’s RXO RXO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-10,598
Closed -$167K 3842
2025
Q2
$167K Sell
10,598
-225
-2% -$3.41K ﹤0.01% 3384
2025
Q1
$207K Buy
10,823
+49
+0.5% +$1.07K ﹤0.01% 3184
2024
Q4
$257K Buy
10,774
+182
+2% +$5.08K ﹤0.01% 2979
2024
Q3
$297K Buy
10,592
+31
+0.3% +$875 ﹤0.01% 2839
2024
Q2
$276K Buy
10,561
+33
+0.3% +$686 ﹤0.01% 2771
2024
Q1
$230K Buy
+10,528
New +$226K ﹤0.01% 2915

Other funds holding RXO

Cambridge Investment Research Advisors's RXO Position: Q3 2025 in Review

Cambridge Investment Research Advisors sold out of RXO (RXO) in Q3 2025, closing a stake of 10,598 shares — an estimated $167K sold.

Cambridge Investment Research Advisors first reported a position in RXO in Q1 2024 and held it in 6 quarters. The position peaked at $297K in Q3 2024. 266 funds tracked by Wall St. Rank hold RXO as of Q3 2025.

  • Cambridge Investment Research Advisors reported no remaining RXO position as of Q3 2025 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 10,598 RXO shares in Q3 2025, an estimated $167K.
  • Cambridge Investment Research Advisors first reported a position in RXO in Q1 2024 and held it in 6 quarters.
  • Cambridge Investment Research Advisors's RXO position peaked at $297K in Q3 2024.
  • 266 funds tracked by Wall St. Rank held RXO as of Q3 2025.

Based on Cambridge Investment Research Advisors's 13F filing for Q3 2025, filed 12 Nov 2025.